Global Point of Care
Rapid tests are essential tools to help diagnose what’s behind your symptoms, so you can treat earlier and get well sooner.
Rapid tests are essential tools to help diagnose what’s behind your symptoms, so you can treat earlier and get well sooner.
There’s rarely a convenient time to take a medical test. The good news is, you no longer need to go out of your way to get fast, reliable, and more accessible testing. From corner pharmacies to local urgent care clinics, our rapid test products are widely available. The same testing technology that is used in doctor's offices & emergency rooms is now also available in convenient care locations.
This program will teach you about rapid tests and how they can quickly identify illnesses like the flu, COVID-19, respiratory syncytial virus (RSV), and strep throat. Rapid molecular testing can help you get treated earlier and get well sooner.
Depending on your symptoms, you may choose to conduct a self test or visit a test provider for a fast and accurate rapid molecular test to be conducted during your visit. Having accurate test results can help your clinician to prescribe the appropriate treatment.
When you don’t feel well, it’s easy to describe your symptoms. What’s much harder is knowing the reason you feel sick in the first place. That’s because a sore throat, cough, and runny or stuffy nose could describe different respiratory infections. And the way you treat them can differ greatly. Learn about different respiratory infections and rapid testing options.
Testing has now become part of our daily conversation due to the COVID-19 pandemic. There are many different types of respiratory diagnostic tests that can be used to test for the flu, COVID-19, RSV, and strep throat.
Rapid molecular tests detect viral RNA or DNA with results available in minutes.
Molecular PCR tests detect viral RNA or DNA.
Detects active infection by identifying a protein from the virus or bacteria that causes that infection.
When a virus first enters your body, it starts multiplying, and you may or may not have symptoms.
As the virus multiplies, the body begins to react to the viral antigens, possibly resulting in symptoms.
As your body starts to fight off infection, your immune system produces IgM and IgG antibodies.
Testing has now become part of our daily conversation due to the COVID-19 pandemic. There are many different types of respiratory diagnostic tests that can be used to test for the flu, COVID-19, RSV, and strep throat.
Rapid molecular tests detect viral RNA or DNA with results available in minutes.
Molecular PCR tests detect viral RNA or DNA and are conducted in a lab.
Detects active infection by identifying a protein from the virus or bacteria that causes that infection.
When a virus first enters your body, it starts multiplying, and you may or may not have symptoms.
As the virus multiplies, the body begins to react to the viral antigens, possibly resulting in symptoms.
As your body starts to fight off infection, your immune system produces IgM and IgG antibodies.
This program will teach you about rapid tests and how they can quickly identify illnesses like the flu, COVID-19, respiratory syncytial virus (RSV), and strep throat. Rapid testing can help you get treated earlier and get well sooner.
Learn about respiratory illnesses and the advanced molecular test technology that offers fast and accurate results. Knowing now means you’ll be treated earlier which can help you get well sooner.
ID NOWTM rapid molecular instrument provides your healthcare professional with timely results, that can inform your treatment, which may include antivirals or antibiotics, so you can get well sooner.
1. Azar, Marwan M., Marie L. Landry. “Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: A Paradigm Shift to Molecular Tests.” Journal of Clinical Microbiology 56, no. 7 (July 2018): e00367-18. https://doi.org/10.1128/JCM.00367-18.
2. Merckx, Joanna, et al. “Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-Analysis.” Annals of Internal Medicine 167, no. 6 (September 19, 2017): 394-409. https://doi.org/10.7326/M17-0848.
3. Franck, Kristina T., et al. “Evaluation of Immuview RSV Antigen Test (SSI Siagnostica) and BinaxNOW RSV Card (Alere) for Rapid Detection of Respiratory Syncytial Virus in Retrospectively and Prospectively Collected Respiratory Samples.” Journal of Medical Virology 92, no. 12 (December 2020): 2992-2998. https://doi.org/10.1002/jmv.26369.
4. Cohen, Jérémie F., et al. “Rapid Antigen Detection Test for Group A Streptococcus in Children With Pharyngitis (Review).” Cochrane Database of Systematic Reviews, no. 7, article no. CD010502, (2016). https://doi.org/10.1002/14651858.CD010502.pub2.
5. “ID Now Influenza A & B 2 Quick Reference Instructions.” Abbott, 2020.
6. “ID Now RSV Quick Reference Instructions.” Abbott, 2020.
7. “ID Now Strep A 2 Quick Reference Instructions.” Abbott, 2020.
8. Hagen, Ashley. “COVID-19 Testing FAQs.” American Society for Microbiology. August 19, 2021. https://asm.org/Articles/2020/April/COVID-19-Testing-FAQs.
9. “Alere i Strep A 2 Package Insert.” Alere, 2018.
10. Shuren, Jeffrey E. “Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Path for COVID-19 Screening Tools, Provides Information to Help Groups Establishing Testing Programs.” Food and Drug Administration. March 16, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-steps-streamline-path-covid-19-screening-tools-provides.
11. Pfeil, Johannes, et al. “Screening for Respiratory Syncytial Virus and Isolation Strategies in Children Hospitalized with Acute Respiratory Tract Infection.” Medicine 93, no. 25 (November 2014):e144. https://doi.org/10.1097/MD.0000000000000144.
A Leader In Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.